Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: EVOKE PHARMA, INC.
CIK: 1403708
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2013-11-13
Last Filing Date: 2025-05-13
SEC Filings
Start End Frame Filed ACCN Value View
2013-07-01 2013-09-30 CY2012Q4I 2013-11-13 0001193125-13-440287 $ 1,190,212 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-12 0001564590-20-024523 $ 24,439,881 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-06 0001564590-20-037301 $ 24,987,975 View
2020-07-01 2020-09-30 CY2019Q3 2020-11-10 0001564590-20-052754 $ 26,146,220 View
2020-01-01 2020-12-31 CY2019 2021-03-11 0001564590-21-012510 $ 25,492,169 View
2021-01-01 2021-03-31 CY2020Q1 2021-05-12 0001564590-21-026996 $ 31,158,065 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-12 0001564590-21-043994 $ 32,386,004 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-10 0001564590-21-056208 $ 32,542,481 View
2013-01-01 2013-12-31 CY2012 2014-03-25 0001193125-14-114409 $ 103,750 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-13 0001193125-14-197023 $ 94,375 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-13 0001193125-14-308400 $ 71,875 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-13 0001564590-14-005646 $ 49,375 View
2014-01-01 2014-12-31 CY2013 2015-03-04 0001564590-15-001287 $ 70,625 View
2015-01-01 2015-03-31 CY2014Q1 2015-05-14 0001564590-15-004303 $ 45,000 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-13 0001564590-15-007249 $ 45,000 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-12 0001564590-15-010586 $ 45,000 View
2015-01-01 2015-12-31 CY2014 2016-03-10 0001564590-16-014408 $ 45,000 View
2016-01-01 2016-03-31 CY2015Q1 2016-05-11 0001564590-16-019101 $ 45,000 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-15 0001564590-16-024351 $ 45,000 View
2016-07-01 2016-09-30 CY2015Q3 2016-11-09 0001564590-16-028633 $ 45,000 View
2016-01-01 2016-12-31 CY2015 2017-03-15 0001564590-17-004426 $ 45,000 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-15 0001564590-17-011039 $ 45,000 View
2018-01-01 2018-03-31 CY2017Q1 2018-05-14 0001564590-18-013308 $ 45,000 View
2018-01-01 2018-03-31 CY2018Q1 2019-05-08 0001564590-19-017213 $ 45,000 View
2018-04-01 2018-06-30 CY2018Q2 2019-08-08 0001564590-19-030433 $ 30,165 View
2018-07-01 2018-09-30 CY2018Q3 2019-11-07 0001564590-19-041384 $ 0 View
2018-01-01 2018-12-31 CY2018 2020-03-12 0001564590-20-010254 $ 18,791 View
2017-04-01 2017-06-30 CY2016Q2 2017-08-14 0001564590-17-017663 $ 15,343,325 View
2017-07-01 2017-09-30 CY2016Q3 2017-11-14 0001564590-17-023771 $ 15,351,295 View
2017-10-01 2017-12-31 CY2016 2018-03-07 0001564590-18-004725 $ 15,368,610 View
2018-04-01 2018-06-30 CY2018Q2 2018-08-09 0001564590-18-021043 $ 16,425,468 View
2018-07-01 2018-09-30 CY2018Q3 2018-11-13 0001564590-18-029310 $ 17,129,649 View
2018-01-01 2018-12-31 CY2018 2019-03-06 0001564590-19-006404 $ 16,602,422 View
2020-01-01 2020-12-31 CY2020 2022-03-08 0001564590-22-009118 $ 444,000 View
2022-04-01 2022-06-30 CY2021Q2I 2022-08-10 0001564590-22-028943 $ 13,450,949 View
2022-01-01 2022-03-31 CY2022Q1I 2022-05-10 0001564590-22-019277 $ 102,000 View
2023-01-01 2023-03-31 CY2023Q1 2023-05-15 0000950170-23-022182 $ 40,112 View
2023-04-01 2023-06-30 CY2023Q2 2023-08-10 0000950170-23-040998 $ 40,112 View
2022-01-01 2022-09-30 CY2021Q3 2022-11-09 0000950170-22-023912 $ 153,671 View
2022-01-01 2022-09-30 CY2023Q3 2023-11-09 0000950170-23-061578 $ 153,671 View
2022-01-01 2022-12-31 CY2021 2023-03-21 0000950170-23-008942 $ 125,000 View
2023-01-01 2023-12-31 CY2023Q4I 2024-03-14 0000950170-24-031435 $ 655,126 View
2023-01-01 2023-12-31 CY2023Q3I 2024-05-14 0000950170-24-059516 $ 5,000,000 View
2024-01-01 2024-03-31 CY2024Q1 2024-05-14 0000950170-24-059596 $ 1,250,800 View
2024-01-01 2024-06-30 CY2024Q2I 2024-08-13 0000950170-24-095776 $ 1,546,497 View
2024-07-01 2024-09-30 CY2024Q3 2024-11-07 0000950170-24-123338 $ -26,733 View
2024-01-01 2024-12-31 CY2024 2025-03-13 0000950170-25-038712 $ 63,119 View
2025-01-01 2025-03-31 CY2025Q1 2025-05-13 0000950170-25-070401 $ 0 View
SEC Facts By Type
Type Name Description View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Line of Credit Facility, Current Borrowing Capacity Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility. View
us-gaap Number of Operating Segments Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall). View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority. View
us-gaap Lease, Cost Amount of lease cost recognized by lessee for lease contract. View
us-gaap Lessee, Operating Lease, Liability, to be Paid Amount of lessee's undiscounted obligation for lease payment for operating lease. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Three Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, Undiscounted Excess Amount Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. View
us-gaap Short-term Lease, Cost Amount of short-term lease cost, excluding expense for lease with term of one month or less. View
us-gaap Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. View
us-gaap Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period. View
us-gaap Financing Receivable, Credit Loss, Expense (Reversal) Amount of credit loss expense (reversal of expense) for financing receivable. View
us-gaap Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) Amount borrowed under the credit facility as of the balance sheet date. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Payable and Accrued Liabilities, Noncurrent Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations. View
us-gaap Accounts Payable, Related Parties, Current Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Payroll Taxes, Current Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustment of Warrants Granted for Services Adjustment for noncash service expenses paid for by granting of warrants. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Accounts Receivable, Allowance for Credit Loss, Current Amount of allowance for credit loss on accounts receivable, classified as current. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Bridge Loan Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing. View
us-gaap Capital Leases, Future Minimum Payments Due, Next Twelve Months Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Conversion of Stock, Shares Issued "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Original Debt, Amount "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Long-term Debt, Gross Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. View
us-gaap Debt Instrument, Fee Amount Amount of the fee that accompanies borrowing money under the debt instrument. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. View
us-gaap Deferred Tax Liabilities, Gross Amount of deferred tax liability attributable to taxable temporary differences. View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
us-gaap Deferred Rent Credit, Noncurrent For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date. View
us-gaap Deferred Tax Assets, Goodwill and Intangible Assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Defined Benefit Plan, Plan Assets, Contributions by Employer Amount of contribution received by defined benefit plan from employer which increases plan assets. View
us-gaap Defined Contribution Plan, Employer Discretionary Contribution Amount Amount of discretionary contributions made by an employer to a defined contribution plan. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash. View
us-gaap Due to Officers or Stockholders Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation, Deduction, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. View
us-gaap Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Fair Value, Assets, Level 1 to Level 2 Transfers, Amount Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. View
us-gaap Fair Value, Assets, Level 2 to Level 1 Transfers, Amount Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. View
us-gaap Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). View
us-gaap Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. View
us-gaap Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) Risk-free interest rate assumption used in valuing an instrument. View
us-gaap Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. View
us-gaap Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Financial Liabilities Fair Value Disclosure Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Income Tax Examination, Penalties and Interest Accrued The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Deferred Charges The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation. View
us-gaap Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. View
us-gaap Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Expense, Long-term Debt Aggregate amount of interest paid or due on all long-term debt. View
us-gaap Interest Expense, Other Amount of interest expense classified as other. View
us-gaap Interest Income (Expense), Nonoperating, Net The net amount of nonoperating interest income (expense). View
us-gaap Interest Income, Other Amount of interest income earned from interest bearing assets classified as other. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Receivable Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. View
us-gaap Inventory, Finished Goods, Gross Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer. View
us-gaap Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Inventory, Raw Materials, Gross Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Investment Income, Nonoperating The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Line of Credit Facility, Increase, Accrued Interest Increase for accrued, but unpaid interest on the credit facility for the period. View
us-gaap Line of Credit Facility, Interest Rate During Period The effective interest rate during the reporting period. View
us-gaap Line of Credit Facility, Maximum Borrowing Capacity Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. View
us-gaap Loans Assumed The fair value of loans assumed in noncash investing or financing activities. View
us-gaap Long-term Debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Long-term Debt, Current Maturities Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Long-Term Debt, Maturity, Year One Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Year Three Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Year Two Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-term Debt, Excluding Current Maturities Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Available to Common Stockholders, Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. View
us-gaap Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued "The number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease. View
us-gaap Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. View
us-gaap Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease. View
us-gaap Operating Leases, Future Minimum Payments Due Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Assets, Current Amount of current assets classified as other. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. View
us-gaap Other Noncash Expense Amount of expense or loss included in net income that result in no cash flow, classified as other. View
us-gaap Paid-in-Kind Interest Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Payments for Repurchase of Initial Public Offering The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public. View
us-gaap Payments for Underwriting Expense Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. View
us-gaap Payments of Loan Costs The cash outflow for loan origination associated cost which is usually collected through escrow. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Bank Debt The cash inflow from bank borrowing during the year. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised. View
us-gaap Proceeds from Issuance of Unsecured Debt The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt. View
us-gaap Proceeds from Lines of Credit Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Receivables, Net, Current The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. View
us-gaap Repayments of Bank Debt The cash outflow to settle a bank borrowing during the year. View
us-gaap Repayments of Lines of Credit Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. View
us-gaap Research and Development Expense (Excluding Acquired in Process Cost) The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. View
us-gaap Research and Development in Process The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. View
us-gaap Restricted Stock, Value, Shares Issued Net of Tax Withholdings Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. View
us-gaap Revenue from Grants (Deprecated 2018-01-31) Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. View
us-gaap Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Warrants Not Settleable in Cash, Fair Value Disclosure Fair value portion of warrants not settleable in cash classified as equity. View
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares authorized for issuance under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Number of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted average grant-date fair value of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value of options vested. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stockholders' Equity Note, Stock Split, Conversion Ratio Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Stock Issued During Period, Shares, Employee Stock Purchase Plans Number of shares issued during the period as a result of an employee stock purchase plan. View
us-gaap Stock Issued During Period, Shares, Period Increase (Decrease) The increase (decrease) during the period in the number of shares issued. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. View
us-gaap Unrecognized Tax Benefits, Period Increase (Decrease) Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns. View
us-gaap Unrecognized Tax Benefits that Would Impact Effective Tax Rate The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Inventory Valuation Reserves Amount of valuation reserve for inventory. View
us-gaap Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year One Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Operating Lease, Expense Amount of operating lease expense. Excludes sublease income. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Inventory, Work in Process, Gross Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer. View
us-gaap 3956661 None View
us-gaap Lessee, Operating Lease, Discount Rate Discount rate used by lessee to determine present value of operating lease payments. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Two Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. View
us-gaap Operating Lease, Payments Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. View
us-gaap Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Deferred Costs, Noncurrent Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. View
us-gaap Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
Chart of Accounts => Accounts
Name View
Capital Leases, Future Minimum Payments Due, Next Twelve Months View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Preferred Stock, Par or Stated Value Per Share View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares View
Deferred Tax Assets, Tax Credit Carryforwards View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority View
Lease, Cost View
Lessee, Operating Lease, Liability, to be Paid View
Lessee, Operating Lease, Liability, to be Paid, Year Three View
Lessee, Operating Lease, Liability, Undiscounted Excess Amount View
Short-term Lease, Cost View
Increase (Decrease) in Employee Related Liabilities View
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year View
Proceeds from Stock Plans View
Financing Receivable, Credit Loss, Expense (Reversal) View
Accounts Payable and Accrued Liabilities, Current View
Accounts Payable and Accrued Liabilities, Noncurrent View
Accounts Payable, Related Parties, Current View
Accrued Payroll Taxes, Current View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Adjustment of Warrants Granted for Services View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Warrant Issued View
Share-based Payment Arrangement, Expense View
Accounts Receivable, Allowance for Credit Loss, Current View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Bridge Loan View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Outstanding View
Common Stock, Capital Shares Reserved for Future Issuance View
Common Stock, Dividends, Per Share, Declared View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Conversion of Stock, Amount Converted View
Conversion of Stock, Shares Converted View
Conversion of Stock, Shares Issued View
Debt Conversion, Original Debt, Amount View
Long-term Debt, Gross View
Debt Instrument, Fee Amount View
Debt Instrument, Unamortized Discount View
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction View
Deferred Tax Liabilities, Gross View
Deferred Offering Costs View
Deferred Rent Credit, Noncurrent View
Deferred Tax Assets, Goodwill and Intangible Assets View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Other View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Valuation Allowance View
Defined Benefit Plan, Plan Assets, Contributions by Employer View
Defined Contribution Plan, Employer Discretionary Contribution Amount View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Dividends, Common Stock, Cash View
Due to Officers or Stockholders View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Deduction, Percent View
Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent View
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent View
Employee-related Liabilities, Current View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) View
Fair Value Adjustment of Warrants View
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount View
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount View
Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) View
Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount View
Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances View
Financial Liabilities Fair Value Disclosure View
General and Administrative Expense View
Income Tax Examination, Penalties and Interest Accrued View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Deferred Charges View
Increase (Decrease) in Inventories View
Increase (Decrease) in Other Noncurrent Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expense View
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants View
Interest Expense View
Interest Expense, Long-term Debt View
Interest Expense, Other View
Interest Income (Expense), Nonoperating, Net View
Interest Income, Other View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Receivable View
Inventory, Finished Goods, Gross View
Inventory, Net View
Inventory, Raw Materials, Gross View
Investment Income, Nonoperating View
Operating Leases, Rent Expense View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Liabilities, Noncurrent View
Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) View
Line of Credit Facility, Current Borrowing Capacity View
Line of Credit Facility, Increase, Accrued Interest View
Line of Credit Facility, Interest Rate During Period View
Line of Credit Facility, Maximum Borrowing Capacity View
Loans Assumed View
Long-term Debt View
Long-term Debt, Current Maturities View
Long-Term Debt, Maturity, Year One View
Long-Term Debt, Maturity, Year Three View
Long-Term Debt, Maturity, Year Two View
Long-term Debt, Excluding Current Maturities View
Notes Payable, Noncurrent View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Available to Common Stockholders, Diluted View
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued View
Nonoperating Income (Expense) View
Number of Operating Segments View
Operating Expenses View
Operating Income (Loss) View
Operating Lease, Liability View
Operating Lease, Liability, Current View
Operating Lease, Right-of-Use Asset View
Operating Leases, Future Minimum Payments Due View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Loss Carryforwards View
Other Assets, Current View
Other Assets, Noncurrent View
Other Liabilities, Current View
Other Liabilities, Noncurrent View
Other Noncash Expense View
Paid-in-Kind Interest View
Payments for Repurchase of Initial Public Offering View
Payments for Underwriting Expense View
Payments of Loan Costs View
Payments of Stock Issuance Costs View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Prepaid Expense, Current View
Proceeds from Bank Debt View
Proceeds from Convertible Debt View
Proceeds from Issuance Initial Public Offering View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised View
Proceeds from Issuance of Unsecured Debt View
Proceeds from Lines of Credit View
Proceeds from Stock Options Exercised View
Receivables, Net, Current View
Repayments of Bank Debt View
Repayments of Lines of Credit View
Research and Development Expense View
Research and Development Expense (Excluding Acquired in Process Cost) View
Research and Development in Process View
Restricted Stock, Value, Shares Issued Net of Tax Withholdings View
Retained Earnings (Accumulated Deficit) View
Revenue from Contract with Customer, Excluding Assessed Tax View
Revenue from Grants (Deprecated 2018-01-31) View
Selling, General and Administrative Expense View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value View
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity Note, Stock Split, Conversion Ratio View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Stock Issued During Period, Shares, Employee Stock Purchase Plans View
Stock Issued During Period, Shares, Period Increase (Decrease) View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Employee Stock Purchase Plan View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Stock Options Exercised View
Unrecognized Tax Benefits View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense View
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions View
Unrecognized Tax Benefits, Period Increase (Decrease) View
Unrecognized Tax Benefits that Would Impact Effective Tax Rate View
Warrants and Rights Outstanding View
Warrants Not Settleable in Cash, Fair Value Disclosure View
Weighted Average Number Diluted Shares Outstanding Adjustment View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation View
Weighted Average Number of Shares Outstanding, Basic View
Inventory Valuation Reserves View
Inventory Write-down View
Lessee, Operating Lease, Liability, to be Paid, Year One View
Operating Lease, Expense View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Inventory, Work in Process, Gross View
3922291 View
Lessee, Operating Lease, Discount Rate View
Lessee, Operating Lease, Liability, to be Paid, Year Two View
Operating Lease, Liability, Noncurrent View
Operating Lease, Payments View
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability View
Deferred Tax Assets, in Process Research and Development View
Deferred Costs, Noncurrent View
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities View
Accounts Receivable, after Allowance for Credit Loss, Current View
Notes Payable, Current View
Interest Payable, Current View
Preferred Stock, Value, Issued View
Proceeds from Warrant Exercises View
Investment Income, Interest View
Other Nonoperating Income (Expense) View